Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01986738 · ClinicalTrials.gov registry record
A Pilot Trial to Determine the Extent of Inter- and Intra-Treatment Organ Motion Using Active Breathing Control Device (ABC) in Patients With Pancreatic Cancer
A clinical trial, sponsored by University of Michigan Rogel Cancer Center.
- Completed
- Registry status
- 9
- Enrollment target
NCT01986738: Completed study, sponsored by University of Michigan Rogel Cancer Center.
NCT01986738 is a clinical trial that has completed, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01986738 has completed, sponsored by University of Michigan Rogel Cancer Center.
- COMPLETED
- Registry status
- 9 participants
- Enrollment target
Study Summary
This is a study to assess the motion of pancreatic tumors during radiation therapy using Computed Tomography (CT) Scans and an Active Breathing Control (ABC) Device.
Primary Outcome
A marker (implanted near the radiation site, prior to treatment, as a point of reference) will be noted in space on an x, y and z plane using a CT scan. The excursion of this marker during treatment will be determined and the distance traveled, as well as the overall vector (distance and magnitude), will be calculated. Later scans will assess changes in the ability to calculate distance traveled and overall vector of travel.
Interventions
- RADIATION Standard Radiation Therapy
- DEVICE Active Breathing Control Device (ABC)
- DEVICE Computed Tomography Scan (CT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2012-01 |
| Est. Completion | 2013-09 |
What the finished NCT01986738 record still lists
NCT01986738 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 9 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Standard Radiation Therapy is the first listed.
NCT01986738 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01986738 about?
NCT01986738 is a clinical study titled "A Pilot Trial to Determine the Extent of Inter- and Intra-Treatment Organ Motion Using Active Breathing Control Device (ABC) in Patients With Pancreatic Cancer". This is a study to assess the motion of pancreatic tumors during radiation therapy using Computed Tomography (CT) Scans and an Active Breathing Control (ABC) Device.
What is the current status of trial NCT01986738?
This trial is currently completed. The enrollment target is 9 participants. The study started on 2012-01. Estimated completion is 2013-09.
What interventions are being tested in trial NCT01986738?
The interventions under investigation include: Standard Radiation Therapy (RADIATION), Active Breathing Control Device (ABC) (DEVICE), Computed Tomography Scan (CT) (DEVICE).
Who is sponsoring clinical trial NCT01986738?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia